Rectal cancer recurrence: how it is detected and what is done
After treatment ends comes the period in which every check-up brings the same question. Two figures put that period in context.
First: 85.4% of recurrences appear within the first three years after surgery, most around two years. Second: after a properly performed total mesorectal excision, local recurrence has fallen to 4-10%, from 10-30% before the technique became widespread, and from 15-40% in the 1970s and 1980s.
The whole surveillance programme follows from the first figure: check-ups are frequent early because that is when almost everything happens, and they space out as risk falls.
Two kinds of recurrence
Local recurrence means the tumour reappearing in the pelvis, in the operated area. It is the form specific to rectal cancer and the most feared, because the pelvis is a narrow space with important structures around it.
Distant recurrence means metastases appearing in other organs — most often liver and lungs.
The distinction matters because treatment differs completely, and because detection methods differ: local recurrence is sought by clinical examination, endoscopy and pelvic MRI; distant recurrence by CT and CEA.
How it is detected
Surveillance is not a single investigation but a combination in which each element covers what the others miss.
Clinical examination and digital rectal examination. In the first two years these are recommended every 3-6 months. In a patient with a low anastomosis, digital examination can detect a recurrence nothing else has yet flagged.
Rectoscopy or colonoscopy. Sees the anastomosis directly.
CEA. It is no use for detecting cancer in the first place — I explained why in the article on blood tests — but in surveillance it becomes useful. A progressive rise, confirmed on a second measurement, can signal a recurrence before it becomes visible on imaging.
Imaging. Thoraco-abdomino-pelvic CT for distant disease; pelvic MRI when local recurrence is suspected. Distinguishing post-operative fibrosis from recurrent tumour is one of the hardest problems in imaging, and often requires PET-CT or reassessment over time.
You can generate the concrete rhythm of these check-ups for your own situation with the surveillance calendar on this site, which also produces a calendar file with reminders.
Why check-ups space out after three years
This is not administrative relaxation but a direct consequence of the statistics: if 85% of recurrences appear in the first three years, the maximum intensity of surveillance has to be placed there.
That does not mean surveillance stops. Colonoscopy continues at longer intervals, because a patient who has had one colorectal cancer remains at risk of developing a second, independent of the first. And late recurrences, though rare, do occur.
What can be done when a recurrence appears
This is the part that makes attending follow-up worthwhile.
Local recurrence found early may be operable with curative intent. The operations are major — sometimes pelvic exenteration — and are done in experienced centres, but they are curative operations, not palliative ones. Radiotherapy is frequently added, if the area has not already been irradiated to the maximum.
Local recurrence found late, after it has invaded bone or nerve structures, is usually inoperable. The difference between those two situations is very often exactly the interval between two missed check-ups.
Distant metastases follow the logic of stage IV: if they are few and resectable, the objective remains cure, with 40-50% five-year survival after resection of liver metastases.
What raises the risk of recurrence
Several things are known in advance and should appear in your medical summary:
- The quality of the mesorectal excision — an incomplete mesorectum raises risk independently of the rest of the treatment
- A positive or borderline circumferential resection margin
- Stage — involved lymph nodes raise the risk
- Vascular or perineural invasion
- Enlarged lateral lymph nodes, over 7 mm short axis, which retain a 15-20% risk of local recurrence even after chemoradiotherapy and surgery
- Tumour perforation during the operation
If several of these apply to you, surveillance should be more frequent than standard. It is worth asking explicitly.
Symptoms that should not wait for the scheduled visit
Surveillance has a calendar; symptoms do not respect it. Come in before your appointment if you develop:
- New, persistent pelvic pain, particularly at night
- Pain radiating into the buttock or leg
- New rectal bleeding
- A new change in bowel habit or sense of incomplete evacuation
- Unexplained weight loss
- New urinary problems
None of these automatically means recurrence — after rectal surgery and radiotherapy there are many benign causes for such symptoms. But none of them is worth waiting three months over.
The psychological part
The anxiety before each check-up is so common that it has a name in the literature. It is not a sign of weakness and should not be hidden from your doctor.
Two things help concretely: knowing in advance what is done at each visit and why, and having the calendar written down somewhere rather than carried in your head. Diffuse uncertainty is harder to bear than a clear schedule.
The information in this article is educational. The surveillance schedule is set individually, according to stage, treatment received and risk factors.